Rehabilitation
Management of
Parkinsons Disease
by dr/ Khaled alsayani
Parkinsons Disease
 Is a chronic, progressive neurodegenerative disorder
with a multifactorial etiology.
 It is superseded only by Alzheimer’s Disease as the most
common neurodegenerative disorder
Demographics of Parkinsons
Disease
 Prevalence of 0.3 % in the US population
 1 – 2% of all persons > 65 yrs old
 4 – 5% of all persons > 85 yrs old
 In US : > 1 million have diagnosis of Parkinsons –
 Usual age at onset – early 60s
 10% of all those affected are < 45 yrs old –
referred to as young onset Parkinsons
 Lifetime risk of Parkinsons for men : 2.0%
 Lifetime risk for women : 1.3%
An Interesting Fact
 The Chinese have the
lowest rates of
Parkinsons Disease
 It has been suggested by
Fahn & Jankovic that
this is may be due to
consumption of large
amounts of green tea by
the Chinese which
contains antioxidants
Etiology
 Parkinsonian symptoms can arise from
either the neuropathological condition PD
(idiopathic PD) or other forms of
Parkinsonism
 For neuropathological PD, 90% of cases are
sporadic
 10% are of genetic origin – 6 different gene
mutations have been identified – the Parkin
genes
 Genetic forms of PD are seen more
frequently in young onset PD
Differential diagnosis of parkinsonism
 Parkinson disease (idiopathic or genetic)
 Parkinson-plus degenerations (dementia with Lewy
bodies, progressive supranuclear palsy,
corticobasal degeneration, multiple system
atrophy)
 Drug-induced parkinsonism (anti-dopaminergics)
Rare but treatable in young people: Wilson disease
and Dopa-responsive dystonia
 Other: “vascular” parkinsonism, brain trauma, CNS
infection
BASAL GANGLIA
 The BG is a collection of nuclei, mainly situated near
the base of the brain, that communicate particularly
with the cortex, thalamus and cerebellum. The BG is
referred to collectively as the automatic processor
‘cruise control’ of the brain (Kirkwood 2006). To
perform normal activities of daily living the BG needs to
be functionally normally. This requires it to converse
with the thalamus and cerebellum to provide
coordinated movement.
The basal ganglia
BG dysfunction
 Impaired performance of well learned motor skills and
movement sequences
 Problems maintaining sufficient movement amplitudes
 Difficulty performing two or more well learned tasks
simultaneously
 Difficulty shifting motor and cognitive sets
 Increased time for mental processing
Risk Factors for Parkinsons
Disease
 The most important risk factor for Parkinsons is advancing age.
 Other environmental or lifestyle risk factors associated with
Parkinsons include :
 Toxins
 Recreational drug abuse
 Head trauma
Idiopathic Parkinsonism
 Most common form of
Parkinsonism :
 Idiopathic form first
described by James
Parkinson, A British
surgeon & paleontologist
in 1817 in his “Essay on
the Shaking Palsy”
Pathophysiology of Idiopathic
Parkinsons
 Pathological hallmark of PD : degeneration of
dopaminergic neurons in the substantia nigra compacta,
resulting in depletion of striatal dopamine
 This neurotransmitter regulates excitatory & inhibitory
outflow from the basal ganglia
 Some of the dopaminergic neurons survive, and these
are found to contain Lewy Bodies
Pathophysiology of Parkinsons
 Lewy Bodies are
eosinophilic
intracytoplasmic
inclusions, composed
of numerous proteins
 Protein accumulation
plays a prominent
role in the
pathogenesis of both
sporadic & familial
forms of PD
 Lewy bodies may
actually be
cytoprotective
 The neurodegenerative process in PD is not limited to
the substantia nigra compacta
 Neuronal loss also happens in other brain regions, which
accounts for the motor & non motor features of the
disease
Rehabilitation Management of Parkinsons Disease.ppt
Diagnosis
Currently, there is no specific test for PD. A doctor may
diagnose PD based on:
 a neurological exam and medical history
 blood and other laboratory tests
 brain scans
 DaTscan
Parkinsons Disease – The Six
Cardinal Features
1. Tremor at rest
2. Rigidity
3. Bradykinesia
4. Loss of postural reflexes
5. Flexed Posture
6. Freezing (Motor Block)
Early Non - Specific Signs of
Parkinsons
 Generalized stiffness
 Pain or Paresthesias of the
limbs – in particular,
shoulder pain
 Constipation
 Low Uric Acid Levels
 Sleeplessness
 Reduction in volume of the
voice
 Loss of sense of smell
 Seborrheic Dermatitis – see
photo on the right
 These symptoms precede
onset of the motor
symptoms of Parkinsons
Common Non - Motor
Features of Parkinsons
 Neuropsychiatric
 Impulse Control Disorders
 Sleep Disorders
 Autonomic Dysfunction – orthostatic hypotension,
hyperhidrosis, hypohidrosis, sexual impotence can
be seen in Parkinsons – but if these features are
noted early in disease process, your patient may
have MSA
 Sensory Symptoms – paresthesias, oral & genital
pain are common – as is olfactory dysfunction
 Other – Fatigue, Seborrhea, Diplopia, Blurred
Vision, Weight Loss
Neuropsychiatric Disorders in
Parkinsons Disease
 Depression
 Anxiety, including panic attacks
 Cognitive Dysfunction
 Dementia
 Psychosis
 Confusion or delirium
 Apathy
Treatment of Motor
Symptoms In PD
 There is no cure for Parkinsons Disease
 No therapy has been shown to slow or
reverse progression of the disease
 The most effective agent, levodopa /
carbidopa has been associated with an
increased risk of motor fluctuations
 The risk of motor fluctuations is greatest
in younger patients
Surgery for PD
 Pallidotomy is no longer performed in the
management of Parkinsons – it is not as
effective as Deep Brain Stimulation (DBS)
 DBS is indicated for patients with drug
resistant motor fluctuations
 Bilateral Deep brain stimulation (DBS) of
the subthalamic nucleus (STN) reduces
both the primary symptoms of PD and its
motor complications including tremor,
bradykinesia, wearing off, dyskinesias,
and dystonia
Effects of DBS
 Reduction in daily levodopa dose by 55%
 69% reduction in dyskinesias
 34.5% improvement in quality of life
Patient Selection for DBS &
Potential Complications
Patient Selection –
 Medically refractory
motor fluctuations or
tremor
 Stable medical problems
 Normal cognitive function
Complications :
 Hemorrhage
 Stroke
 Infection
 Failure of stimulator
 Memory Loss
Aims of Physiotherapy
 Maintain and improve levels of function and
independence, which will help to improve a person’s
quality of life
 Use exercise and movement strategies to improve
mobility
 Correct and improve abnormal movement patterns and
posture, where possible
 Maximize muscle strength and joint flexibility
 Correct and improve posture and balance, and minimise
risks of falls
 Maintain a good breathing pattern and effective cough
 Educate the person with Parkinson’s and their carer or
family members
 Enhance the effects of drug therapy
 Exercise has been proven to maintain health and well-
being in Parkinson’s and now importantly it is shown to
play a big role in addressing secondary prevention
(focusing on strength, endurance, flexibility, functional
practice and balance).
 Exercise for neuroprotection focuses on endurance and
uses motor learning principles approaches, such as
mental imagery and dual task training
 Exercise undertaken in a group setting has the added
value of providing a social connection to those
becoming increasingly isolated as the condition
progresses, or for those who are newly diagnosed, so
they can see the benefits of maintaining exercise and
activity
 Physical activity, in particular, aerobic exercise might
slow down the motor skill degeneration and depression.
Furthermore, it increases the quality of life of patients
with Parkinson’s
 Inspiratory muscle training on lung functions in patients
with mild-to-moderate Parkinson's suggests a better
outcome
 Quality of life may be increased when performing
strength training against an external resistance.
 with Motor-Cognitive Dual-Task training
 The European Guideline provides a section that
describes the use of motor
 Visual cueing
 Auditory cueing
 Attention .
 Proprioceptive cueing
Exercise Interventions in
Parkinsons Disease
 A meta – analysis found
that physical &
occupational therapy
improved gait speed,
stride length, and ADL,
but no change in the
neurological cardinal
signs – De Goede et al,
Archives of PM&R, 2001
 Train your patient to
perform gestes
antagonistes, such as
marching with the
metronome – this is not
frequently done by
therapists
Weight Supported Ambulation
Training
 Weight supported
ambulation training with
Lite Gait or Biodex has
been shown to improve
gait in Parkinsons
patients, as published in
the Archives of PM&R
Speech & Language Pathology
Services
 Helpful in the management of dysarthria associated
with Parkinsons
 For PD related hypomimia, training the PD patient to
shout has been found to be effective – this is known as
the Lee Silverman technique
Equipment for the Parkinsons
Patient
 Rolling Walkers are
best – canes &
standard walkers are
frequently carried by
the patient
 Shower chairs
 Grab Bars
 Raised Toilet Seats
with armrests – ie
Versaframe
 Chairs with arms to
assist patient to lower
themselves to the chair
without falling
Considerations for the
Primary Care Physician
 Parkinsons patients have a lower incidence of cancer
than the general population with the exception of
malignant melanoma – Parkinsons patients are at 2 x
greater risk of developing melanoma than the general
population.

More Related Content

PPTX
PPTX
Parkinson's Disease & Physiotherapy Management
PDF
Rehabilitation Management of Parkinsons Disease.pdf
PPTX
Parkinson Disease
PDF
PARKINSON'S DISEASE and its PT management
PPTX
Parkinsons.pptxskjbvwdnvowdnv0iwdnv0iqwnvoiwqnviqwnv
PDF
management of Parkinson disease for physios.pdf
PPTX
Parkinson's disease Seminar Presentation
Parkinson's Disease & Physiotherapy Management
Rehabilitation Management of Parkinsons Disease.pdf
Parkinson Disease
PARKINSON'S DISEASE and its PT management
Parkinsons.pptxskjbvwdnvowdnv0iwdnv0iqwnvoiwqnviqwnv
management of Parkinson disease for physios.pdf
Parkinson's disease Seminar Presentation

Similar to Rehabilitation Management of Parkinsons Disease.ppt (20)

PPTX
Physiotherapy Assessment and management of Parkinson's disease
PPTX
Parkinson's disease
PPTX
parkinsonism and parkinsons disease.pptx
PPT
Rehabilitation_Management_of_Parkinsons_Disease.ppt
PPTX
PARKINSONIAN DISORDERS.pptx
PPTX
Parkinson’s Disease presentation by Dr. Kenneth Ikott
PPTX
Parkinson's disease by waheed javed
PPTX
Nursing management of patient with PARKINSONS DISEASE
PPTX
🔴Parkinson’s Ds. Neuro Physiotherapy 🔴DM me on Instagram for free notes in an...
PPTX
Prakash park
PPTX
Parkinson's manasi india 17
PPTX
Parkinson’s disease
PDF
parkinson disease for physiotherapy students
PDF
parkinson disease (1).pdf
DOCX
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
PPT
Parkinson study case
PPTX
Presentation1.pptx
PPTX
Parkinsons disease V Pharm.D
PDF
Parkinson's disease
PDF
Parkinson's disease
Physiotherapy Assessment and management of Parkinson's disease
Parkinson's disease
parkinsonism and parkinsons disease.pptx
Rehabilitation_Management_of_Parkinsons_Disease.ppt
PARKINSONIAN DISORDERS.pptx
Parkinson’s Disease presentation by Dr. Kenneth Ikott
Parkinson's disease by waheed javed
Nursing management of patient with PARKINSONS DISEASE
🔴Parkinson’s Ds. Neuro Physiotherapy 🔴DM me on Instagram for free notes in an...
Prakash park
Parkinson's manasi india 17
Parkinson’s disease
parkinson disease for physiotherapy students
parkinson disease (1).pdf
PARKINSONS DISEASE MEDICAL TREATMENT AND PHYSIOTHERAPY MANAGEMENT
Parkinson study case
Presentation1.pptx
Parkinsons disease V Pharm.D
Parkinson's disease
Parkinson's disease
Ad

More from AhmedMufleh1 (20)

PPT
medicalisation_presentation_(arabic).ppt
PPTX
Physiotherapy Pocketbooks. burn .pptx
PPTX
8- Driving physiotherapy ergonomics .pptx
PPTX
stress rehabilitation physiotherapy .pptx
PPTX
4- Hip mobilization Hip mobilization.pptx
PPTX
shoulder therapy of the shoulder complex.pptx
PPT
RHEUMATOLOGIC DISORDERS RHEUMATOLOGIC DISORDERS.ppt
PPTX
Cerebral palsy. Cerebral pediatric .pptx
PPT
Enzyme EnzymeEnzymeEnzymeEnzymeEnzyme.ppt
PPTX
Neurological assessment Neurological assessment.en.ar.pptx
PPT
Evaluation of Non-Life Threatening Injuries - 2.en.ar.pptx.ppt
PPTX
abdominal surgery.pptx
PPTX
acne.pptx
PPTX
Hip mobilization.pptx
PPTX
Physiotherapy in Reconstructive Surgery .pptx
PPTX
Physiotherapy in Reconstructive Surgery .pptx
PPTX
Wristand hand-2.pptx
PPTX
Orthopedic + erb palsy.pptx
PPTX
elbow injury.pptx
PPTX
Rickets.pptx
medicalisation_presentation_(arabic).ppt
Physiotherapy Pocketbooks. burn .pptx
8- Driving physiotherapy ergonomics .pptx
stress rehabilitation physiotherapy .pptx
4- Hip mobilization Hip mobilization.pptx
shoulder therapy of the shoulder complex.pptx
RHEUMATOLOGIC DISORDERS RHEUMATOLOGIC DISORDERS.ppt
Cerebral palsy. Cerebral pediatric .pptx
Enzyme EnzymeEnzymeEnzymeEnzymeEnzyme.ppt
Neurological assessment Neurological assessment.en.ar.pptx
Evaluation of Non-Life Threatening Injuries - 2.en.ar.pptx.ppt
abdominal surgery.pptx
acne.pptx
Hip mobilization.pptx
Physiotherapy in Reconstructive Surgery .pptx
Physiotherapy in Reconstructive Surgery .pptx
Wristand hand-2.pptx
Orthopedic + erb palsy.pptx
elbow injury.pptx
Rickets.pptx
Ad

Recently uploaded (20)

PDF
Journal of Dental Science - UDMY (2021).pdf
PDF
0520_Scheme_of_Work_(for_examination_from_2021).pdf
PDF
PUBH1000 - Module 6: Global Health Tute Slides
PPTX
2025 High Blood Pressure Guideline Slide Set.pptx
PPT
REGULATION OF RESPIRATION lecture note 200L [Autosaved]-1-1.ppt
PPTX
BSCE 2 NIGHT (CHAPTER 2) just cases.pptx
PPTX
Macbeth play - analysis .pptx english lit
PDF
LIFE & LIVING TRILOGY - PART (3) REALITY & MYSTERY.pdf
PPTX
CAPACITY BUILDING PROGRAMME IN ADOLESCENT EDUCATION
PDF
The TKT Course. Modules 1, 2, 3.for self study
PDF
Compact First Student's Book Cambridge Official
PDF
Laparoscopic Colorectal Surgery at WLH Hospital
PDF
fundamentals-of-heat-and-mass-transfer-6th-edition_incropera.pdf
PDF
Journal of Dental Science - UDMY (2022).pdf
PDF
M.Tech in Aerospace Engineering | BIT Mesra
PDF
semiconductor packaging in vlsi design fab
DOCX
Cambridge-Practice-Tests-for-IELTS-12.docx
PDF
Controlled Drug Delivery System-NDDS UNIT-1 B.Pharm 7th sem
PDF
African Communication Research: A review
PDF
Nurlina - Urban Planner Portfolio (english ver)
Journal of Dental Science - UDMY (2021).pdf
0520_Scheme_of_Work_(for_examination_from_2021).pdf
PUBH1000 - Module 6: Global Health Tute Slides
2025 High Blood Pressure Guideline Slide Set.pptx
REGULATION OF RESPIRATION lecture note 200L [Autosaved]-1-1.ppt
BSCE 2 NIGHT (CHAPTER 2) just cases.pptx
Macbeth play - analysis .pptx english lit
LIFE & LIVING TRILOGY - PART (3) REALITY & MYSTERY.pdf
CAPACITY BUILDING PROGRAMME IN ADOLESCENT EDUCATION
The TKT Course. Modules 1, 2, 3.for self study
Compact First Student's Book Cambridge Official
Laparoscopic Colorectal Surgery at WLH Hospital
fundamentals-of-heat-and-mass-transfer-6th-edition_incropera.pdf
Journal of Dental Science - UDMY (2022).pdf
M.Tech in Aerospace Engineering | BIT Mesra
semiconductor packaging in vlsi design fab
Cambridge-Practice-Tests-for-IELTS-12.docx
Controlled Drug Delivery System-NDDS UNIT-1 B.Pharm 7th sem
African Communication Research: A review
Nurlina - Urban Planner Portfolio (english ver)

Rehabilitation Management of Parkinsons Disease.ppt

  • 2. Parkinsons Disease  Is a chronic, progressive neurodegenerative disorder with a multifactorial etiology.  It is superseded only by Alzheimer’s Disease as the most common neurodegenerative disorder
  • 3. Demographics of Parkinsons Disease  Prevalence of 0.3 % in the US population  1 – 2% of all persons > 65 yrs old  4 – 5% of all persons > 85 yrs old  In US : > 1 million have diagnosis of Parkinsons –  Usual age at onset – early 60s  10% of all those affected are < 45 yrs old – referred to as young onset Parkinsons  Lifetime risk of Parkinsons for men : 2.0%  Lifetime risk for women : 1.3%
  • 4. An Interesting Fact  The Chinese have the lowest rates of Parkinsons Disease  It has been suggested by Fahn & Jankovic that this is may be due to consumption of large amounts of green tea by the Chinese which contains antioxidants
  • 5. Etiology  Parkinsonian symptoms can arise from either the neuropathological condition PD (idiopathic PD) or other forms of Parkinsonism  For neuropathological PD, 90% of cases are sporadic  10% are of genetic origin – 6 different gene mutations have been identified – the Parkin genes  Genetic forms of PD are seen more frequently in young onset PD
  • 6. Differential diagnosis of parkinsonism  Parkinson disease (idiopathic or genetic)  Parkinson-plus degenerations (dementia with Lewy bodies, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy)  Drug-induced parkinsonism (anti-dopaminergics) Rare but treatable in young people: Wilson disease and Dopa-responsive dystonia  Other: “vascular” parkinsonism, brain trauma, CNS infection
  • 7. BASAL GANGLIA  The BG is a collection of nuclei, mainly situated near the base of the brain, that communicate particularly with the cortex, thalamus and cerebellum. The BG is referred to collectively as the automatic processor ‘cruise control’ of the brain (Kirkwood 2006). To perform normal activities of daily living the BG needs to be functionally normally. This requires it to converse with the thalamus and cerebellum to provide coordinated movement.
  • 9. BG dysfunction  Impaired performance of well learned motor skills and movement sequences  Problems maintaining sufficient movement amplitudes  Difficulty performing two or more well learned tasks simultaneously  Difficulty shifting motor and cognitive sets  Increased time for mental processing
  • 10. Risk Factors for Parkinsons Disease  The most important risk factor for Parkinsons is advancing age.  Other environmental or lifestyle risk factors associated with Parkinsons include :  Toxins  Recreational drug abuse  Head trauma
  • 11. Idiopathic Parkinsonism  Most common form of Parkinsonism :  Idiopathic form first described by James Parkinson, A British surgeon & paleontologist in 1817 in his “Essay on the Shaking Palsy”
  • 12. Pathophysiology of Idiopathic Parkinsons  Pathological hallmark of PD : degeneration of dopaminergic neurons in the substantia nigra compacta, resulting in depletion of striatal dopamine  This neurotransmitter regulates excitatory & inhibitory outflow from the basal ganglia  Some of the dopaminergic neurons survive, and these are found to contain Lewy Bodies
  • 13. Pathophysiology of Parkinsons  Lewy Bodies are eosinophilic intracytoplasmic inclusions, composed of numerous proteins  Protein accumulation plays a prominent role in the pathogenesis of both sporadic & familial forms of PD  Lewy bodies may actually be cytoprotective
  • 14.  The neurodegenerative process in PD is not limited to the substantia nigra compacta  Neuronal loss also happens in other brain regions, which accounts for the motor & non motor features of the disease
  • 16. Diagnosis Currently, there is no specific test for PD. A doctor may diagnose PD based on:  a neurological exam and medical history  blood and other laboratory tests  brain scans  DaTscan
  • 17. Parkinsons Disease – The Six Cardinal Features 1. Tremor at rest 2. Rigidity 3. Bradykinesia 4. Loss of postural reflexes 5. Flexed Posture 6. Freezing (Motor Block)
  • 18. Early Non - Specific Signs of Parkinsons  Generalized stiffness  Pain or Paresthesias of the limbs – in particular, shoulder pain  Constipation  Low Uric Acid Levels  Sleeplessness  Reduction in volume of the voice  Loss of sense of smell  Seborrheic Dermatitis – see photo on the right  These symptoms precede onset of the motor symptoms of Parkinsons
  • 19. Common Non - Motor Features of Parkinsons  Neuropsychiatric  Impulse Control Disorders  Sleep Disorders  Autonomic Dysfunction – orthostatic hypotension, hyperhidrosis, hypohidrosis, sexual impotence can be seen in Parkinsons – but if these features are noted early in disease process, your patient may have MSA  Sensory Symptoms – paresthesias, oral & genital pain are common – as is olfactory dysfunction  Other – Fatigue, Seborrhea, Diplopia, Blurred Vision, Weight Loss
  • 20. Neuropsychiatric Disorders in Parkinsons Disease  Depression  Anxiety, including panic attacks  Cognitive Dysfunction  Dementia  Psychosis  Confusion or delirium  Apathy
  • 21. Treatment of Motor Symptoms In PD  There is no cure for Parkinsons Disease  No therapy has been shown to slow or reverse progression of the disease  The most effective agent, levodopa / carbidopa has been associated with an increased risk of motor fluctuations  The risk of motor fluctuations is greatest in younger patients
  • 22. Surgery for PD  Pallidotomy is no longer performed in the management of Parkinsons – it is not as effective as Deep Brain Stimulation (DBS)  DBS is indicated for patients with drug resistant motor fluctuations  Bilateral Deep brain stimulation (DBS) of the subthalamic nucleus (STN) reduces both the primary symptoms of PD and its motor complications including tremor, bradykinesia, wearing off, dyskinesias, and dystonia
  • 23. Effects of DBS  Reduction in daily levodopa dose by 55%  69% reduction in dyskinesias  34.5% improvement in quality of life
  • 24. Patient Selection for DBS & Potential Complications Patient Selection –  Medically refractory motor fluctuations or tremor  Stable medical problems  Normal cognitive function Complications :  Hemorrhage  Stroke  Infection  Failure of stimulator  Memory Loss
  • 25. Aims of Physiotherapy  Maintain and improve levels of function and independence, which will help to improve a person’s quality of life  Use exercise and movement strategies to improve mobility  Correct and improve abnormal movement patterns and posture, where possible  Maximize muscle strength and joint flexibility  Correct and improve posture and balance, and minimise risks of falls  Maintain a good breathing pattern and effective cough  Educate the person with Parkinson’s and their carer or family members  Enhance the effects of drug therapy
  • 26.  Exercise has been proven to maintain health and well- being in Parkinson’s and now importantly it is shown to play a big role in addressing secondary prevention (focusing on strength, endurance, flexibility, functional practice and balance).  Exercise for neuroprotection focuses on endurance and uses motor learning principles approaches, such as mental imagery and dual task training  Exercise undertaken in a group setting has the added value of providing a social connection to those becoming increasingly isolated as the condition progresses, or for those who are newly diagnosed, so they can see the benefits of maintaining exercise and activity
  • 27.  Physical activity, in particular, aerobic exercise might slow down the motor skill degeneration and depression. Furthermore, it increases the quality of life of patients with Parkinson’s  Inspiratory muscle training on lung functions in patients with mild-to-moderate Parkinson's suggests a better outcome  Quality of life may be increased when performing strength training against an external resistance.
  • 28.  with Motor-Cognitive Dual-Task training
  • 29.  The European Guideline provides a section that describes the use of motor  Visual cueing  Auditory cueing  Attention .  Proprioceptive cueing
  • 30. Exercise Interventions in Parkinsons Disease  A meta – analysis found that physical & occupational therapy improved gait speed, stride length, and ADL, but no change in the neurological cardinal signs – De Goede et al, Archives of PM&R, 2001  Train your patient to perform gestes antagonistes, such as marching with the metronome – this is not frequently done by therapists
  • 31. Weight Supported Ambulation Training  Weight supported ambulation training with Lite Gait or Biodex has been shown to improve gait in Parkinsons patients, as published in the Archives of PM&R
  • 32. Speech & Language Pathology Services  Helpful in the management of dysarthria associated with Parkinsons  For PD related hypomimia, training the PD patient to shout has been found to be effective – this is known as the Lee Silverman technique
  • 33. Equipment for the Parkinsons Patient  Rolling Walkers are best – canes & standard walkers are frequently carried by the patient  Shower chairs  Grab Bars  Raised Toilet Seats with armrests – ie Versaframe  Chairs with arms to assist patient to lower themselves to the chair without falling
  • 34. Considerations for the Primary Care Physician  Parkinsons patients have a lower incidence of cancer than the general population with the exception of malignant melanoma – Parkinsons patients are at 2 x greater risk of developing melanoma than the general population.